BIOMAT Database Logo BIOMAT Database Logo

6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2) 1977

K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda

UI MeSH Term Description Entries
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011465 Prostaglandins, Synthetic Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity. PG Analog,PG Analogs,Prostaglandin Analog,Prostaglandin Analogs,Prostaglandin Analogue,Synthetic Prostaglandin,Prostaglandin Analogues,Synthetic Prostaglandins,Analog, PG,Analog, Prostaglandin,Analogs, PG,Analogs, Prostaglandin,Analogue, Prostaglandin,Analogues, Prostaglandin,Prostaglandin, Synthetic

Related Publications

K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Effect of 6,9-thia prostaglandin I2 (a stable PGI2 analogue) on passive cutaneous anaphylaxis (PCA) in rats.
October 1979, Japanese journal of pharmacology,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Synthesis of ZK-96,480: a chemically and metabolically stable potent prostacyclin analogue.
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Dipyridamole: a potent stimulator of prostacyclin (PGI2) biosynthesis.
January 1980, British journal of pharmacology,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
An antiserum against 9-deoxy-6,9-epoxy-PGF1alpha recognizes and binds PGI2 (prostacyclin).
April 1978, Prostaglandins,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
April 1980, Prostaglandins,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.
January 1983, Advances in prostaglandin, thromboxane, and leukotriene research,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
September 1978, The Journal of pharmacy and pharmacology,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
December 1984, British journal of clinical pharmacology,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Prostacyclin (PGI2).
January 1983, Intensive care medicine,
K C Nicolaou, and W E Barnette, and G P Gasic, and R L Magolda
Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
December 1990, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!